<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-49-551C85">
 <label>85</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <string-name>
    <surname>Stoker</surname>, 
    <given-names>T.B.</given-names>
   </string-name>, 
   <string-name>
    <surname>Torsney</surname>, 
    <given-names>K.M.</given-names>
   </string-name> and 
   <string-name>
    <surname>Barker</surname>, 
    <given-names>R.A</given-names>
   </string-name>
  </person-group>. (
  <year>2018</year>) 
  <chapter-title>Pathological mechanisms and clinical aspects of GBA1 mutation-associated Parkinson's disease</chapter-title>. In 
  <source>Parkinson's Disease: Pathogenesis and Clinical Aspects. Codon Publications</source> (Stoker, T.B. and Greenland, J.C. eds), Brisbane (AU): Codon Publications, 
  <comment>[cited 2020 Nov 11]. Available from:</comment>
  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/30702840" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ncbi.nlm.nih.gov/pubmed/30702840</ext-link>
 </mixed-citation>
</ref>
